Latest Commercialization News

Ovanti Limited’s US subsidiary has secured a key partnership with Mastercard’s Finicity to enhance its upcoming Flote BNPL platform, aiming to revolutionize consumer finance with real-time data insights.

Sparc Hydrogen has appointed Alana Barlow as its inaugural CEO, marking a strategic move to accelerate commercialisation of its innovative photocatalytic water splitting technology for green hydrogen.

DMC Mining's progress in Guinea is stalled as the government halts new exploration licences until after the December presidential election, prompting a 12-month extension on acquisition terms.

Imugene has secured FDA backing to advance its allogeneic CAR T therapy, azer-cel, into a pivotal Phase 3 trial targeting difficult-to-treat diffuse large B-cell lymphoma (DLBCL), including patients relapsed after prior CAR-T treatment.

Chimeric Therapeutics has won FDA Orphan Drug Designation for its CHM CDH17 CAR-T therapy targeting gastric cancer, advancing its clinical development with regulatory incentives and potential market exclusivity.

Telix Pharmaceuticals has dosed the first patient in the randomized expansion phase of its pivotal ProstACT Global Phase 3 trial for TLX591, targeting advanced prostate cancer. The trial is expanding globally, with regulatory submissions underway in the US and Europe.

Lincoln Minerals has partnered with Revera Energy to explore a green hydrogen-fueled iron pellet plant at the Eyre Magnetite Project, aiming to advance sustainable steel production in South Australia.

Mandrake Resources has inked a binding agreement with DISA Technologies to recover uranium and critical minerals from abandoned mine waste across its expansive Utah Project, tapping into a growing US government-backed market.

NH3 Clean Energy has signed a pivotal Memorandum of Understanding with Japan’s ITOCHU Corporation to develop clean ammonia bunkering operations in Western Australia’s Pilbara region and across the Asia Pacific by 2030.

Audeara Limited has secured its largest-ever Australian wholesale purchase order worth $560,000, driving year-to-date wholesale revenues to $1.75 million and matching full FY25 figures. The company is also expanding manufacturing into China, signaling growing international ambitions.

Ardea Resources updates its Definitive Feasibility Study for the Kalgoorlie Nickel Project, confirming a streamlined processing approach and a new sale product that could enhance project economics and market reach.

Anson Resources' subsidiary A1 Lithium has signed a non-binding MoU with Nusano to supply high-purity lithium chloride from Utah’s Green River project for advanced nuclear isotope production. This marks a strategic step into the nuclear technology supply chain alongside ongoing electric vehicle market efforts.